NEWB

COM:NEWBURYPHARMA

Newbury Pharma

Stock

SEK

Last Close

3.32

25/11 08:40

Market Cap

91.21M

Beta: -

Volume Today

4.70K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Nov '22	Feb '23	May '23	Aug '23	Nov '23	Feb '24	May '24	Aug '24
net income	-5.22M -				-3.36M -			2.35M -
depreciation and amortization
deferred income tax
stock based compensation
change in working capital		-1.31M -	-4.77M 264.96%	701K 114.70%	-2.32M 430.96%	-3.53M 52.28%	-1.74M 50.67%	-2.23M 27.65%
accounts receivables
inventory
accounts payables
other working capital								-2.23M -
other non cash items
net cash provided by operating activities		-5.85M -	-8.53M 45.87%	-3.63M 57.44%	-5.68M 56.38%	-7.98M 40.49%	-10.18M 27.64%	130K 101.28%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites								-166K -
net cash used for investing activites		-724K -	266K 136.74%	-54K 120.30%	-2.34M 4,238.89%	-1.28M 45.41%	834K 165.21%	-166K 119.90%
debt repayment
common stock issued
common stock repurchased
dividends paid
other financing activites								-92K -
net cash used provided by financing activities		337K -	36K 89.32%	-714K 2,083.33%	15.39M 2,255.46%	-229K 101.49%	18.37M 8,120.52%	-92K 100.50%
effect of forex changes on cash
net change in cash		-6.24M -	-8.23M 31.98%	-4.40M 46.55%	7.37M 267.52%	-9.48M 228.71%	9.02M 195.09%	-128K 101.42%
cash at beginning of period		27.39M -	21.16M 22.76%	12.93M 38.90%	8.53M 34.03%	15.90M 86.41%	6.41M 59.67%	15.43M 140.66%
cash at end of period		21.16M -	12.93M 38.90%	8.53M 34.03%	15.90M 86.41%	6.41M 59.67%	15.43M 140.66%	15.30M 0.83%
operating cash flow		-5.85M -	-8.53M 45.87%	-3.63M 57.44%	-5.68M 56.38%	-7.98M 40.49%	-10.18M 27.64%	130K 101.28%
capital expenditure
free cash flow		-5.85M -	-8.53M 45.87%	-3.63M 57.44%	-5.68M 56.38%	-7.98M 40.49%	-10.18M 27.64%	130K 101.28%

All numbers in SEK (except ratios and percentages)